ACM
ABMD

Aubrey Capital Management’s Abiomed Inc ABMD Stock Holding History

Aubrey Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,000
Closed -$5.31M – 61
2020
Q2 		$5.31M Buy
+22,000
New +$4.42M 2.38% 13
2019
Q2 		– Sell
-12,580
Closed -$3.59M – 38
2019
Q1 		$3.59M Hold
12,580
– – 1.73% 24
2018
Q4 		$4.09M Sell
12,580
-600
-5% -$208K 2.85% 11
2018
Q3 		$5.93M Sell
13,180
-3,850
-23% -$1.52M 2.93% 10
2018
Q2 		$6.06M Sell
17,030
-3,570
-17% -$1.29M 2.83% 12
2018
Q1 		$3.11M Hold
20,600
– – 2.64% 17
2017
Q4 		$3.11M Buy
+20,600
New +$3.85M 2.64% 17

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aubrey Capital Management's ABMD Position: Q3 2020 in Review

Aubrey Capital Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 22,000 shares — an estimated $5.31M sold.

Aubrey Capital Management first reported a position in ABMD in Q4 2017 and held it in 7 quarters. The position peaked at $6.06M in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Aubrey Capital Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Aubrey Capital Management sold 22,000 Abiomed Inc shares in Q3 2020, an estimated $5.31M.
  • Aubrey Capital Management first reported a position in Abiomed Inc in Q4 2017 and held it in 7 quarters.
  • Aubrey Capital Management's Abiomed Inc position peaked at $6.06M in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Aubrey Capital Management's 13F filing for Q3 2020, filed 29 Oct 2020.